Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of North Carolina |
---|---|
Information provided by: | The University of North Carolina, Chapel Hill |
ClinicalTrials.gov Identifier: | NCT00450242 |
Condition | Intervention | Phase |
---|---|---|
Vulvar Vestibulitis |
Drug: 5% topical lidocaine ointment |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study |
Official Title: | Use of 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis |
Estimated Enrollment: | 56 |
Study Start Date: | December 2006 |
Estimated Study Completion Date: | April 2008 |
Ages Eligible for Study: | 18 Years to 50 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Grace Fulton, BS | 919 966-8202 ext 226 | grace_fulton@med.unc.edu |
Contact: Jacqueline Rohl, MD | 919 966-8202 ext 285 | jrohl@med.unc.edu |
United States, North Carolina | |
University of North Carolina | Recruiting |
Chapel Hill, North Carolina, United States, 27599 |
Principal Investigator: | Jacqueline Rohl, MD | UNC Division of Advanced Laparoscopy and Pelvic Pain |
Study Director: | Denniz Zolnound, MD | UNC- Division of Advanced Laparoscopy and Pelvic Pain |
Study ID Numbers: | 05-2332 |
Study First Received: | March 21, 2007 |
Last Updated: | March 21, 2007 |
ClinicalTrials.gov Identifier: | NCT00450242 |
Health Authority: | United States: Institutional Review Board |
vulvar vestibulitis vestibulitis |
Genital Diseases, Female Vulvar Vestibulitis Lidocaine Vulvar Vestibulitis Syndrome Vulvar Diseases |
Sensory System Agents Therapeutic Uses Physiological Effects of Drugs Central Nervous System Depressants Anesthetics Cardiovascular Agents |
Anti-Arrhythmia Agents Peripheral Nervous System Agents Vulvitis Central Nervous System Agents Pharmacologic Actions Anesthetics, Local |